Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.65 Billion CNY | 24.53% |
| 2022 | 1.32 Billion CNY | 36.38% |
| 2021 | 973.69 Million CNY | 3.68% |
| 2020 | 939.14 Million CNY | 21.56% |
| 2019 | 772.6 Million CNY | 11.33% |
| 2018 | 693.99 Million CNY | 28.95% |
| 2017 | 538.2 Million CNY | 19.15% |
| 2016 | 451.69 Million CNY | 81.32% |
| 2015 | 249.11 Million CNY | -1.48% |
| 2014 | 252.87 Million CNY | 79.0% |
| 2013 | 141.26 Million CNY | 88.03% |
| 2012 | 75.12 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 480.44 Million CNY | 0.74% |
| 2024 Q1 | 426.22 Million CNY | -8.72% |
| 2024 Q2 | 476.92 Million CNY | 11.9% |
| 2023 Q1 | 355.06 Million CNY | -11.97% |
| 2023 FY | 1.65 Billion CNY | 24.53% |
| 2023 Q4 | 466.94 Million CNY | 6.93% |
| 2023 Q3 | 436.7 Million CNY | 10.58% |
| 2023 Q2 | 394.93 Million CNY | 11.23% |
| 2022 FY | 1.32 Billion CNY | 36.38% |
| 2022 Q1 | 308.47 Million CNY | 0.16% |
| 2022 Q4 | 403.34 Million CNY | 13.62% |
| 2022 Q3 | 354.99 Million CNY | 35.96% |
| 2022 Q2 | 261.09 Million CNY | -15.36% |
| 2021 FY | 973.69 Million CNY | 3.68% |
| 2021 Q4 | 307.97 Million CNY | 29.89% |
| 2021 Q3 | 237.1 Million CNY | -8.97% |
| 2021 Q1 | 168.14 Million CNY | -30.17% |
| 2021 Q2 | 260.46 Million CNY | 54.91% |
| 2020 Q1 | 110.74 Million CNY | -47.82% |
| 2020 Q4 | 240.78 Million CNY | 8.15% |
| 2020 FY | 939.14 Million CNY | 21.56% |
| 2020 Q2 | 364.98 Million CNY | 229.55% |
| 2020 Q3 | 222.63 Million CNY | -39.0% |
| 2019 Q3 | 221.91 Million CNY | 10.74% |
| 2019 Q2 | 200.39 Million CNY | 45.18% |
| 2019 Q1 | 138.03 Million CNY | 0.0% |
| 2019 Q4 | 212.26 Million CNY | -4.35% |
| 2019 FY | 772.6 Million CNY | 11.33% |
| 2018 FY | 693.99 Million CNY | 28.95% |
| 2017 FY | 538.2 Million CNY | 19.15% |
| 2016 Q1 | 95.99 Million CNY | 66.27% |
| 2016 FY | 451.69 Million CNY | 81.32% |
| 2016 Q4 | 129.84 Million CNY | 0.0% |
| 2016 Q3 | 129.84 Million CNY | 35.26% |
| 2016 Q2 | 95.99 Million CNY | 0.0% |
| 2015 Q3 | 57.73 Million CNY | -13.6% |
| 2015 Q2 | 66.82 Million CNY | -0.0% |
| 2015 Q1 | 66.82 Million CNY | -8.33% |
| 2015 Q4 | 57.73 Million CNY | 0.0% |
| 2015 FY | 249.11 Million CNY | -1.48% |
| 2014 FY | 252.87 Million CNY | 79.0% |
| 2014 Q2 | 53.53 Million CNY | -0.0% |
| 2014 Q1 | 53.53 Million CNY | 22.73% |
| 2014 Q4 | 72.89 Million CNY | 0.0% |
| 2014 Q3 | 72.89 Million CNY | 36.15% |
| 2013 Q2 | 27.01 Million CNY | -0.0% |
| 2013 Q4 | 43.62 Million CNY | 0.0% |
| 2013 FY | 141.26 Million CNY | 88.03% |
| 2013 Q3 | 43.62 Million CNY | 61.5% |
| 2013 Q1 | 27.01 Million CNY | 0.0% |
| 2012 FY | 75.12 Million CNY | 0.0% |